Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

CRBN vs CIGEX overlap: 45% of top holdings shared

Bottom line

How much do CRBN and CIGEX overlap?

45% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 20.0% of CRBN's assets and 35.5% of CIGEX's. They share a meaningful core but differ in the rest of the portfolio.

CRBN holds far more positions (1,116 vs 70), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

CRBNCIGEX
Weight overlap (top 25)45%
Shared holdings11
Weight in shared holdings20.0%35.5%
Total positions1,11670
Expense ratio0.2%1.15%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings CRBN and CIGEX have in common

Holding% of CRBN% of CIGEXOverlap
Nvidia Corporation4.56%6.86%4.56%
Microsoft Corporation3.24%1.59%1.59%
Amazon.com, Inc.2.61%3.37%2.61%
Alphabet Inc.2.18%4.60%2.18%
Taiwan Semiconductor Manufacturing Company Limited1.83%4.98%1.83%
Broadcom Inc.1.73%1.58%1.58%
Eli Lilly And Company0.90%4.05%0.90%
Samsung Electronics Co., Ltd.0.80%3.20%0.80%
Advanced Micro Devices, Inc.0.78%1.90%0.78%
Johnson & Johnson0.77%1.49%0.77%
ASML Holding N.V.0.66%1.86%0.66%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in CRBN

  1. Apple Inc. — 4.50%
  2. Alphabet Inc. — 1.51%
  3. Meta Platforms, Inc. — 1.20%
  4. Jpmorgan Chase & Co. — 0.97%
  5. Micron Technology, Inc. — 0.94%
  6. Tesla, Inc. — 0.90%
  7. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 0.89%
  8. Visa Inc. — 0.65%
  9. SK hynix Inc. — 0.64%
  10. Berkshire Hathaway Inc. — 0.60%
  11. Walmart Inc. — 0.51%
  12. Cisco Systems, Inc. — 0.50%
  13. Abbvie Inc. — 0.48%
  14. Mastercard Incorporated — 0.47%

Only in CIGEX

  1. State Street Global Advisors — 2.74%
  2. Rolls-Royce Holdings PLC — 2.66%
  3. UniCredit SpA — 2.19%
  4. TechnipFMC PLC — 2.18%
  5. PriceSmart Inc — 1.85%
  6. Philip Morris International Inc — 1.83%
  7. Sumitomo Mitsui Financial Group Inc — 1.64%
  8. Royalty Pharma PLC — 1.55%
  9. Chubb Ltd — 1.51%
  10. Cardinal Health Inc — 1.49%
  11. ORIX Corp — 1.49%
  12. Goldman Sachs Group Inc/The — 1.48%
  13. Viking Holdings Ltd — 1.48%
  14. State Street Corp — 1.32%

Asset mix

Asset typeCRBNCIGEX
Stocks98.9%95.7%
Cash & short-term funds1.1%2.7%
Other0.9%—
Preferred stock—0.8%
Equity derivatives—0.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryCRBNCIGEX
US62.4%58.4%
JP5.2%7.9%
GB2.6%7.4%
TW3.2%5.0%
KR2.4%4.8%
CA3.4%1.3%
NL1.7%2.8%
CH2.3%1.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do CRBN and CIGEX overlap?
About 45% by weight. 11 securities appear in both funds' top 25 holdings; they make up 20.0% of CRBN's assets and 35.5% of CIGEX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do CRBN and CIGEX have in common?
The largest shared holdings are Nvidia Corporation, Amazon.com, Inc., Alphabet Inc., Taiwan Semiconductor Manufacturing Company Limited, Microsoft Corporation.
Should I own both CRBN and CIGEX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, CRBN or CIGEX?
CRBN is broader, with 1,116 positions versus 70 for CIGEX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.